Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Acrizanib (LHA510) as Maintenance Therapy in Wet AMD
NCT02355028Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2015
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
A Phase 2 trial of acrizanib in exudative age-related macular degeneration, sponsored by Alcon Inc.. Started Mar 2015; status: completed.
02
Drugs
acrizanib
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT02355028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02355028.